These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15713700)

  • 21. Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters.
    Nieuwlaat WA; Hermus AR; Sivro-Prndelj F; Corstens FH; Huysmans DA
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5330-6. PubMed ID: 11701700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The treatment of multinodular large non-toxic goiter using repeated doses of radioiodine (preliminary report)].
    Pisarek M; Baczyk M; Gryczyńska M; Sowiński J
    Endokrynol Pol; 2007; 58(1):18-26. PubMed ID: 17354201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioiodine plus recombinant human thyrotropin do not cause acute airway compression and are effective in reducing multinodular goiter.
    Albino CC; Graf H; Paz-Filho G; Diehl LA; Olandoski M; Sabbag A; Buchpiguel C
    Braz J Med Biol Res; 2010 Mar; 43(3):303-9. PubMed ID: 20401438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human thyrotropin is helpful in the follow-up and 131I therapy of patients with thyroid cancer: a report of the results and benefits using recombinant human thyrotropin in clinical routine.
    Kohlfuerst S; Igerc I; Lind P
    Thyroid; 2005 Apr; 15(4):371-6. PubMed ID: 15876162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular assessment of hyperthyroid patients with multinodular goiter before and after radioiodine treatment preceded by stimulation with recombinant human TSH.
    Barca MF; Gruppi C; Oliveira MT; Romão R; Cárdia MS; Rubio I; Knobel M; Medeiros-Neto G
    Endocrine; 2007 Oct; 32(2):175-81. PubMed ID: 18026694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy.
    Fast S; Nielsen VE; Bonnema SJ; Hegedüs L
    Eur J Endocrinol; 2009 Apr; 160(4):517-28. PubMed ID: 19106244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An outline concerning the potential use of recombinant human thyrotropin for improving radioiodine therapy of multinodular goiter.
    Medeiros-Neto G; Marui S; Knobel M
    Endocrine; 2008 Apr; 33(2):109-17. PubMed ID: 18491237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 30-year perspective on radioiodine therapy of benign nontoxic multinodular goiter.
    Bonnema SJ; Hegedüs L
    Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):379-84. PubMed ID: 19623060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.
    Mariani G; Ferdeghini M; Augeri C; Villa G; Taddei GZ; Scopinaro G; Boni G; Bodei L; Rabitti C; Molinari E; Bianchi R
    Cancer Biother Radiopharm; 2000 Apr; 15(2):211-7. PubMed ID: 10803328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study).
    Meier CA; Braverman LE; Ebner SA; Veronikis I; Daniels GH; Ross DS; Deraska DJ; Davies TF; Valentine M; DeGroot LJ
    J Clin Endocrinol Metab; 1994 Jan; 78(1):188-96. PubMed ID: 8288703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human thyrotropin-stimulated radioiodine therapy of large nodular goiters facilitates tracheal decompression and improves inspiration.
    Bonnema SJ; Nielsen VE; Boel-Jørgensen H; Grupe P; Andersen PB; Bastholt L; Hegedüs L
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3981-4. PubMed ID: 18664541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uses for recombinant human TSH in patients with thyroid cancer and nodular goiter.
    Woodmansee WW; Haugen BR
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):163-73. PubMed ID: 15272910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use for recombinant human TSH in patients with toxic and non-toxic nodular goiter].
    Jedrzejuk D; Milewicz A
    Postepy Hig Med Dosw (Online); 2005 May; 59():188-92. PubMed ID: 15928602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. rhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of (131)I.
    Menzel C; Kranert WT; Döbert N; Diehl M; Fietz T; Hamscho N; Berner U; Grünwald F
    J Nucl Med; 2003 Jul; 44(7):1065-8. PubMed ID: 12843221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishing and Monitoring an Effective Management of Benign Nontoxic Multinodular Goitre in Kuwait "Utilizing Two Different Dose Levels of Recombinant Human TSH in Combination with Radioactive Iodine".
    Al-Shammeri I; Masoomi M; Al-Shammeri N; Al-Abdali F; Al-Shagooli A
    Gulf J Oncolog; 2024 May; 1(45):49-63. PubMed ID: 38774933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects.
    Ramirez L; Braverman LE; White B; Emerson CH
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2836-9. PubMed ID: 9284706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early sequential changes in serum thyroglobulin after radioiodine ablation for thyroid cancer: possible clinical implications for recombinant human thyrotropin-aided therapy.
    Taïeb D; Lussato D; Guedj E; Roux F; Mundler O
    Thyroid; 2006 Feb; 16(2):177-9. PubMed ID: 16676403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial.
    Nielsen VE; Bonnema SJ; Hegedüs L
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1317-22. PubMed ID: 16434453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.